InnovativeBioresearchClassic (INNBCL)

InnovativeBioresearchClassic (INNBCL) is a decentralized cryptocurrency that aims to revolutionize the field of biomedical research. The coin is developed by Innovative Bioresearch Ltd, a biotech company founded by research scientist Dr. Jonathan Fior. Its primary goal is to bring disruptive innovation to the fields of HIV, cancer, and regeneration research using the power of blockchain technology. INNBCL serves as the heart of the DeSci ecosystem, supporting the development of novel vaccine research for various diseases and enabling access to DApps for biomedical science.

The INNBCL decentralized exchange allows users to swap or provide liquidity by integrating Uniswap V3 liquidity pools. Additionally, INNBCL offers a biomedical DApp called INNBCL DApp, which utilizes Web3 to store text, images, audio, and video on the blockchain. With a simple interface, INNBCL DApp allows users to record biomedical data on the chain permanently and can also be utilized as a decentralized storage solution for businesses.

For those interested in the innovative HIV research conducted by Innovative Bioresearch, INNBCL provides information on SupT1 cell infusion therapy, a highly innovative cell-based therapy for HIV. The company addresses the need for disruptive solutions in the biomedical field and aims to improve human life through its decentralized biomedical research efforts. INNBCL also serves as the means of payment to access Innovative Bioresearch’s products and services.